Precision Biosciences

DTIL

NASDAQHealth Care

Income Statement

Total Revenue$68.7M

Gross Profit$68.7M

Operating Income$-26.16M

EBITDA$13.53M

EBIT$8.95M

Pre-tax Income$-46.61M

Net Income$7.17M

Cash Equivalent$122.78M

Total Debt$19.31M

Book Value$58.29M

Book Value Per Share8.11

Return on Equity (ROE)+12.71%

Return on Assets (ROA)+5.25%

Return on Invested Capital (ROI)+9.11%

Net Profit Margin+10.43%

Current Ratio6.34

Quick Ratio5.91

Long-Term Debt / Equity0.40